Startups.Bio showcases an emerging biotech startup each week, selected by the analyst team at VentureRadar from the 10,000s of companies we track.
Avrion Therapeutics targets genetically-linked neurodegenerative diseases using precision gene therapy to enable long-term solutions. Founded in 2020, based on more than 10 years of research at the Swiss Federal Institute of Technology EPFL Brain Mind Institute, Avrion says its first-in-class precision gene therapy platform can selectively and safely target discrete cells in the brain including […]
Initium Therapeutics was established to develop innovative antibody-based therapeutics, including pursuing new therapeutic targets in fibrosis, immuno-oncology and hemophilia. Initium was established in June of 2020 as a spin-off of South Korea-based Tiumbio in order to expand its capability to antibody drug development platforms. Initium says that using its unique antibody development platforms of DNA […]
Clarametyx Biosciences is targeting a universal structure within biofilms in order to eliminate bacterial defenses and drastically increase their vulnerability to immune or antibiotic intervention. Founded n 2020, Clarametyx is focused on addressing the challenge of biofilm-associated infections. These infections are often resistant to immune response or standard antibiotic regimens due to an extracellular matrix […]